Annual Operating Expenses
$2.80 B
+$194.46 M+7.46%
31 December 2023
Summary:
Jazz Pharmaceuticals annual total operating expenses is currently $2.80 billion, with the most recent change of +$194.46 million (+7.46%) on 31 December 2023. During the last 3 years, it has risen by +$317.85 million (+12.80%). JAZZ annual operating expenses is now at all-time high.JAZZ Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$683.15 M
-$31.33 M-4.39%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly total operating expenses is currently $683.15 million, with the most recent change of -$31.33 million (-4.39%) on 30 September 2024. Over the past year, it has dropped by -$81.05 million (-10.61%). JAZZ quarterly operating expenses is now -10.61% below its all-time high of $764.20 million, reached on 31 December 2023.JAZZ Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -10.6% |
| 3 y3 years | +12.8% | -3.9% |
| 5 y5 years | +101.3% | +40.8% |
JAZZ Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +12.8% | -10.6% | +11.8% |
| 5 y | 5 years | at high | +101.3% | -10.6% | +105.0% |
| alltime | all time | at high | +3670.2% | -10.6% | +2863.8% |
Jazz Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $683.15 M(-4.4%) |
| June 2024 | - | $714.48 M(-2.2%) |
| Mar 2024 | - | $730.29 M(-4.4%) |
| Dec 2023 | $2.80 B(+7.5%) | $764.20 M(+9.5%) |
| Sept 2023 | - | $697.60 M(-0.6%) |
| June 2023 | - | $702.14 M(+10.2%) |
| Mar 2023 | - | $637.11 M(-8.1%) |
| Dec 2022 | $2.61 B(+5.0%) | $693.14 M(+6.9%) |
| Sept 2022 | - | $648.58 M(-0.8%) |
| June 2022 | - | $653.98 M(+7.1%) |
| Mar 2022 | - | $610.89 M(-14.1%) |
| Dec 2021 | $2.48 B(+71.4%) | $711.20 M(+7.0%) |
| Sept 2021 | - | $664.52 M(-5.4%) |
| June 2021 | - | $702.21 M(+73.3%) |
| Mar 2021 | - | $405.27 M(-0.2%) |
| Dec 2020 | $1.45 B(+4.1%) | $405.95 M(+15.1%) |
| Sept 2020 | - | $352.59 M(+5.8%) |
| June 2020 | - | $333.30 M(-6.7%) |
| Mar 2020 | - | $357.35 M(-26.3%) |
| Dec 2019 | $1.39 B(+25.2%) | $485.15 M(+50.9%) |
| Sept 2019 | - | $321.42 M(+7.2%) |
| June 2019 | - | $299.97 M(+5.3%) |
| Mar 2019 | - | $284.94 M(+7.5%) |
| Dec 2018 | $1.11 B(+24.3%) | $265.06 M(+4.3%) |
| Sept 2018 | - | $254.02 M(-5.8%) |
| June 2018 | - | $269.67 M(-16.5%) |
| Mar 2018 | - | $322.89 M(+23.3%) |
| Dec 2017 | $894.66 M(+16.6%) | $261.95 M(+19.5%) |
| Sept 2017 | - | $219.20 M(+10.3%) |
| June 2017 | - | $198.67 M(-7.5%) |
| Mar 2017 | - | $214.85 M(+8.8%) |
| Dec 2016 | $767.18 M(+12.4%) | $197.46 M(-0.6%) |
| Sept 2016 | - | $198.62 M(+5.4%) |
| June 2016 | - | $188.45 M(+3.2%) |
| Mar 2016 | - | $182.66 M(+2.2%) |
| Dec 2015 | $682.53 M | $178.70 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $180.96 M(+14.1%) |
| June 2015 | - | $158.63 M(-3.4%) |
| Mar 2015 | - | $164.25 M(+1.2%) |
| Dec 2014 | $617.88 M(+45.4%) | $162.23 M(+10.7%) |
| Sept 2014 | - | $146.55 M(-4.5%) |
| June 2014 | - | $153.44 M(-1.4%) |
| Mar 2014 | - | $155.65 M(+34.6%) |
| Dec 2013 | $424.98 M(+37.2%) | $115.63 M(+8.7%) |
| Sept 2013 | - | $106.36 M(+0.2%) |
| June 2013 | - | $106.16 M(+9.6%) |
| Mar 2013 | - | $96.83 M(+6.9%) |
| Dec 2012 | $309.71 M(+137.3%) | $90.56 M(+3.4%) |
| Sept 2012 | - | $87.59 M(+20.8%) |
| June 2012 | - | $72.52 M(+22.8%) |
| Mar 2012 | - | $59.05 M(+40.6%) |
| Dec 2011 | $130.50 M(+27.4%) | $42.01 M(+17.7%) |
| Sept 2011 | - | $35.69 M(+30.5%) |
| June 2011 | - | $27.34 M(+7.3%) |
| Mar 2011 | - | $25.47 M(+10.5%) |
| Dec 2010 | $102.43 M(-0.4%) | $23.05 M(-15.3%) |
| Sept 2010 | - | $27.22 M(+0.4%) |
| June 2010 | - | $27.10 M(+8.1%) |
| Mar 2010 | - | $25.06 M(+4.0%) |
| Dec 2009 | $102.88 M(-47.0%) | $24.09 M(-2.7%) |
| Sept 2009 | - | $24.76 M(-7.2%) |
| June 2009 | - | $26.67 M(-2.5%) |
| Mar 2009 | - | $27.36 M(-28.5%) |
| Dec 2008 | $194.19 M(-0.5%) | $38.25 M(-4.3%) |
| Sept 2008 | - | $39.97 M(-33.2%) |
| June 2008 | - | $59.84 M(+6.6%) |
| Mar 2008 | - | $56.14 M(-20.9%) |
| Dec 2007 | $195.18 M(+68.3%) | $70.94 M(+90.0%) |
| Sept 2007 | - | $37.33 M(-32.5%) |
| June 2007 | - | $55.34 M(+75.3%) |
| Mar 2007 | - | $31.57 M |
| Dec 2006 | $115.94 M(+56.1%) | - |
| Dec 2005 | $74.29 M | - |
FAQ
- What is Jazz Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly operating expenses year-on-year change?
What is Jazz Pharmaceuticals annual total operating expenses?
The current annual operating expenses of JAZZ is $2.80 B
What is the all time high annual operating expenses for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total operating expenses is $2.80 B
What is Jazz Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of JAZZ is $683.15 M
What is the all time high quarterly operating expenses for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total operating expenses is $764.20 M
What is Jazz Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, JAZZ quarterly total operating expenses has changed by -$81.05 M (-10.61%)